# Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft.

> **NCT04615260** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Artoss Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Degenerative Disc Disease
- Spondylolisthesis

## Interventions

- **DEVICE:** NanoBone

## Key facts

- **NCT ID:** NCT04615260
- **Lead sponsor:** Artoss Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-07-19
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-04-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04615260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04615260, "Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft.". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04615260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*